ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding ADC Therapeutics SA changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 41 | −14 |
| Shares | 45.4M | 1.27M | 39.5M | −4.63M (−10.5%) |
| Value | $97.5M | $2.73M | $35.4M | −$59.4M (−62.7%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held ADC Therapeutics SA at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gladius Capital Management LP | 19,752 | $17.7K | 0.01% |
| The PNC Financial Services Group, Inc. | 250 | $224 | 0.00% |
| Federation des caisses Desjardins du Quebec | 20 | $18 | 0.00% |
| Cornerstone Planning Group LLC | 14 | $13 | 0.00% |
Sold out (18)
Institutions that held ADC Therapeutics SA at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| JPMorgan Chase & Co | 2,760,081 | $5.93M |
| Price T Rowe Associates Inc | 1,221,838 | $2.63M |
| Barclays PLC | 314,925 | $677.1K |
| Manufacturers Life Insurance Company, The | 146,566 | $315.1K |
| Laurion Capital Management LP | 120,881 | $259.9K |
| Ameriprise Financial Inc | 89,526 | $192.5K |
| TD Asset Management Inc | 74,690 | $160.6K |
| Squarepoint Ops LLC | 44,641 | $96.0K |
| Cubist Systematic Strategies, LLC | 27,437 | $59.0K |
| Susquehanna International Group, LLP | 18,788 | $40.4K |
| Virtu Financial LLC | 18,835 | $40.0K |
| Jane Street Group, LLC | 16,467 | $35.4K |
| Verition Fund Management LLC | 14,649 | $31.5K |
| Cypress Capital Group | 10,000 | $21.5K |
| Aquatic Capital Management LLC | 2,300 | $5.00K |
| Citigroup Inc | 1,834 | $3.94K |
| Northwestern Mutual Wealth Management Co | 100 | $215 |
| Salem Investment Counselors Inc | 35 | $76 |
Not filed for Q3 2023 yet (1)
Institutions that held ADC Therapeutics SA at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 1,270,132 | $2.73M |